The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
The US is the world's largest producer of bioethanol as renewable liquid fuel, with more than 200 commercial plants processing over 16 billion gallons per year. Plants typically use dry grind ...
Cells are remarkably complex structures, containing a vast repertoire of macromolecules, organelles, and other compartments that orchestrate the tasks required for life. For in-depth studies of their ...
Retired engineer and inventor Ed Evenson might have a 0.00001 chance of changing the way math is taught in Illinois, but you won’t catch him giving a half-effort. Evenson, of Rolling Meadows, says ...
We have examined the possibility that pectin solubilization and cell separation in fruit may be due to organic acids disrupting calcium bridges between pectic polysaccharides. With fruit from a wild ...
Market Overview: The Global Plasma Fractionation Market was valued at USD 30.87 billion in 2022 and is projected to grow at a robust CAGR of over 8.3% during the forecast period from 2023 to 2030.
The Impact Assessment Agency of Canada (IAAC) assessed the Josephburg Condensate Fractionation Project, a new refinery northeast of Edmonton, Alberta, and determined that its potential adverse effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback